| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 86.559 | 89.991 | - | 88.427 | 33.412 | 28.884 | 63.657 | 77.442 | 105.021 | 78.915 |
| Total Income - EUR | 92.447 | 96.684 | - | 92.142 | 34.471 | 28.957 | 64.261 | 78.776 | 105.186 | 81.690 |
| Total Expenses - EUR | 109.245 | 105.093 | - | 111.098 | 48.372 | 42.087 | 60.902 | 72.789 | 90.106 | 77.631 |
| Gross Profit/Loss - EUR | -16.798 | -8.409 | - | -18.956 | -13.901 | -13.130 | 3.359 | 5.987 | 15.080 | 4.059 |
| Net Profit/Loss - EUR | -16.798 | -8.409 | - | -19.846 | -14.246 | -13.412 | 2.717 | 5.207 | 14.024 | 2.432 |
| Employees | 18 | 14 | - | 6 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Ellisse Clinique S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 19.451 | 13.585 | - | 140.209 | 128.743 | 118.211 | 108.421 | 103.443 | 96.453 | 95.428 |
| Current Assets | 43.396 | 123.757 | - | 65.797 | 68.081 | 66.488 | 57.255 | 53.328 | 68.882 | 59.442 |
| Inventories | 39.274 | 118.604 | - | 53.937 | 58.862 | 54.956 | 42.405 | 40.903 | 47.640 | 52.798 |
| Receivables | 1.439 | 1.352 | - | 4.550 | 4.894 | 5.135 | 7.859 | 5.783 | 7.535 | 2.762 |
| Cash | 2.683 | 3.801 | - | 7.310 | 4.325 | 6.398 | 6.991 | 6.643 | 13.707 | 3.882 |
| Shareholders Funds | -240.938 | -246.889 | - | -270.898 | -279.898 | -288.004 | -278.901 | -274.559 | -259.703 | -255.819 |
| Social Capital | 5.669 | 5.611 | - | 5.415 | 5.310 | 5.210 | 5.094 | 5.110 | 5.095 | 5.066 |
| Debts | 304.489 | 384.945 | - | 477.577 | 477.382 | 473.350 | 445.209 | 431.965 | 426.973 | 412.614 |
| Income in Advance | 17 | 17 | - | 16 | 16 | 16 | 15 | 15 | 15 | 15 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8559 - 8559" | |||||||||
| CAEN Financial Year |
9602
|
|||||||||
Comments - Ellisse Clinique S.r.l.